Key financial metrics and fundamentals for Xilio Therapeutics, Inc. (XLO).
Market Cap
$49.0M
P/E Ratio
-20.21
Forward P/E
--
EPS
$-0.42
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High